Why the study?
Heart failure carries high mortality, reduced quality of life, and substantial healthcare costs, and implementing a telehealth care program might address these challenges and improve outcomes.
Does telehealth care reduce mortality and readmission in heart failure patients?
Does telehealth care reduce mortality and readmission in heart failure patients?
Telehealth care via Bluetooth-enabled equipment significantly reduces all-cause mortality and rehospitalization rates in heart failure patients over one year.
Supports telehealth in HF cohorts; leaves open randomized confirmation of benefits.
IntroductionHeart failure (HF) is associated with high incidence and mortality rates, limited physical activity, decreased quality of life, and increased healthcare expenses. Implementing a Telehealth Care (TC) HF program might address these challenges while improving patient outcomes.MethodWe conducted a retrospective observational study using electronic medical record data. The study recruited 916 participants screened with ICD-10 code I50 from 2016 to 2020. After data screening, 210 participants were divided into a remote care group and a control group using propensity score matching. Patients in the remote care group received TC visits for HF management via Bluetooth-enabled equipment, while those in the control group received typical care.ResultsAmong the 587 participants, those who received TC experienced reduced rates of all-cause mortality and readmission within one year, as well as lower rates of cardiovascular disease and HF-related readmission. However, there was no significant difference in cardiovascular disease mortality compared to the control group within one year. Kaplan-Meier time-event curves showed that there were significant differences in survival analysis.DiscussionTC significantly reduced all-cause mortality and rehospitalization rates in HF patients, highlighting its role in enhancing patient outcomes through remote monitoring. Although cardiovascular-specific mortality within one year did not exhibit significant differences, the TC group had fewer HF-related readmissions. This suggests improved disease management and self-care in this group. The findings demonstrate the potential of TC as a valuable tool in standard HF care, particularly for patients with comorbidities, such as diabetes and coronary heart disease.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: